tiprankstipranks
Advertisement
Advertisement
GoodRx price target raised to $4 from $3.50 at Citi
PremiumThe FlyGoodRx price target raised to $4 from $3.50 at Citi
17d ago
GoodRx price target raised to $4 from $3 at TD Cowen
Premium
The Fly
GoodRx price target raised to $4 from $3 at TD Cowen
19d ago
Analyst Maintains Buy on GoodRx as High-Value Segments Gain Traction; Price Target Kept at $3.50
Premium
Ratings
Analyst Maintains Buy on GoodRx as High-Value Segments Gain Traction; Price Target Kept at $3.50
20d ago
GoodRx raises FY26 revenue view to $765M-$785M from $750M-$780M
PremiumThe FlyGoodRx raises FY26 revenue view to $765M-$785M from $750M-$780M
24d ago
GoodRx offers Ozempic pill for Type 2 diabetes
Premium
The Fly
GoodRx offers Ozempic pill for Type 2 diabetes
29d ago
GoodRx Names Thomas Chan Chief Accounting Officer
Premium
Company Announcements
GoodRx Names Thomas Chan Chief Accounting Officer
1M ago
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
PremiumThe FlyGoodRx announces resignation of Chief Accounting Officer Romin Nabiey
2M ago
Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand
Premium
Market News
Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand
2M ago
GoodRx Awards Performance-Based Bonus to Chief Accounting Officer
Premium
Company Announcements
GoodRx Awards Performance-Based Bonus to Chief Accounting Officer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100